Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer-Reference-Cited by-同舟云学术

Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer

Published:2013-12-08 Issue:4 Volume:17 Page:718-724
ISSN:1436-3291
Container-title:Gastric Cancer
language:en
Short-container-title:Gastric Cancer

Author:

Di Lauro Luigi,Vici Patrizia,Belli Franca,Tomao Silverio,Fattoruso Silvia Ileana,Arena Maria Grazia,Pizzuti Laura,Giannarelli Diana,Paoletti Giancarlo,Barba Maddalena,Sergi Domenico,Maugeri-Saccà Marcello

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Gastroenterology,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10120-013-0321-3.pdf

Reference37 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. Cervantes A, Roda D, Tarazona N, Roselló S, Pérez-Fidalgo JA. Current questions for the treatment of advanced gastric cancer. Cancer Treat Rev. 2013;39:60–7.

3. Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163–8.

4. Murad AM, Santiago FF, Petroianu A, Rocha PR, Rodrigues MA, Rausch M. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer (Phila). 1993;72:37–41.

5. Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587–91.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023;Gastric Cancer;2024-02-22

2. Anticancer effect of aromatic isoniazid derivatives in human gastric adenocarcinoma cells;Toxicology and Applied Pharmacology;2023-12

3. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2022-02

4. Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology;Oncology in Clinical Practice;2020-05-15

5. Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer;Anti-Cancer Drugs;2020-03